Form 4: Eli Lilly Director Acquires Shares Through Deferral Plan

Mary Lynne Hedley, a director at Eli Lilly, acquired 11 shares of common stock through a deferral plan, with the shares to be settled after her separation from service.

Summary

• Mary Lynne Hedley, a director at Eli Lilly & Co, has reported a transaction involving the acquisition of 11 shares of common stock.
• The shares were acquired on June 17, 2024, at a price of $885.01 per share.
• These shares were acquired as part of the Lilly Directors' Deferral Plan, in lieu of cash compensation.
• The shares will be settled in common stock after Ms. Hedley's separation from service.
• Ms. Hedley also has indirect ownership of 98 shares through a trust, but disclaims beneficial ownership except for her pecuniary interest.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to director compensation, which is generally viewed as neutral to slightly positive. The acquisition of shares by a director can be seen as a sign of confidence in the company.

Positives

• The acquisition of shares by a director can be seen as a positive sign of confidence in the company's future.

Future Outlook

The acquired shares will be settled in common stock following the reporting person's separation from service.

Industry Context

This is a routine filing related to director compensation and is common practice for publicly traded companies.

Comparison to Industry Standards

• Director share acquisitions through deferral plans are a common practice among publicly traded companies, particularly in the pharmaceutical industry.
• Many companies offer similar deferral plans to align director interests with long-term shareholder value.
• The specific terms of the Lilly Directors' Deferral Plan are not detailed in this document, but such plans typically involve a vesting period or a trigger event such as separation from service.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it aligns director interests with the company's long-term performance.

Key Dates

Keywords

Eli Lilly, Director, Share Acquisition, Deferral Plan, Stock Units, Beneficial Ownership, LLY